This article combines the relevant provisions of the "Interim Measures" and the "Advertising Law of the People's Republic of China" (hereinafter referred to as the "Advertising Law"), and discusses the compliance issues in three aspects of medical device advertising for operators' reference.
Cosmetic publicity compliance is an important part of cosmetic enterprise business compliance. Product claims are not compliant, on the one hand harm the interests of consumers; On the other hand, it also brings great operational risks to the enterprise. Faced with the red line of rules that cannot be crossed, the current Chinese cosmeceutical market is more suitable for well-known foreign cosmeceutical brands or pharmaceutical companies to use the formed brand awareness to harvest the market, but not suitable for the creation of new cosmeceutical brands.
Blockchain decentralized autonomous organizations meet the requirements of joint operation, shared profits and losses, and shared risks, and are partnerships. At this stage, the liability of the partnership members can be borne by the joint system, which is borne by the parties holding the Token respectively.
The compliance of cosmetic products mainly involves five aspects, such as product ingredients, labels, packaging, production qualifications, and product approvals, and operators should pay systematic attention to them.
